The global healthcare landscape is witnessing a paradigm shift from traditional hospital-centric models to patient-centric In-Home IV Therapy Systems. As an industry leader, Hangzhou StavroCare Medical understands that the demand for professional-grade medical equipment in residential settings has surged by over 25% annually. This growth is driven by the rising prevalence of chronic diseases, an aging global population, and the cost-effectiveness of home-based recovery.
In regions like North America and Europe, the "Hospital-at-Home" initiative has turned In-Home IV therapy into a critical industrial segment. Modern systems are no longer just gravity-fed tubes; they are sophisticated, IoT-enabled devices that ensure precision, safety, and real-time monitoring. As a China Top Factory, we bridge the gap between advanced technology and accessible healthcare, exporting high-precision systems to over 50 countries.
Years R&D Experience
Global Installations
CE/FDA Compliance
Technical Support
Next-generation IV systems are integrated with cloud platforms, allowing physicians to monitor infusion rates and patient vitals remotely via mobile apps.
Artificial Intelligence algorithms now predict potential occlusion or air-in-line issues before they occur, ensuring 99.9% patient safety during unsupervised home use.
The trend is moving toward portable, lightweight designs that allow patients to maintain mobility and quality of life during therapy sessions.
Combining IV therapy with physical rehabilitation (like Tecar or Laser therapy) to accelerate recovery times in post-operative patients.
Big data helps healthcare providers optimize treatment protocols by analyzing patient response patterns across thousands of decentralized home units.
A focus on eco-friendly materials and reusable components to reduce the environmental footprint of medical waste in home care.
Institutions are seeking reliable OEM partners to customize IV systems that sync with their specific Electronic Health Record (EHR) systems.
Wholesalers in SE Asia, MENA, and LATAM require cost-effective yet high-durability machines that can withstand diverse environmental conditions.
Agencies look for "Plug-and-Play" interfaces that are intuitive for non-medical caregivers or the patients themselves to operate safely.
We provide comprehensive localized training materials and multilingual interfaces to ensure seamless adoption in any global market.
As a premier In-Home IV Therapy System Factory in Hangzhou, China, we offer unparalleled advantages in the global supply chain:
Hangzhou StavroCare Medical Co., Ltd. is a professional manufacturer specializing in advanced physiotherapy equipment and health assessment systems. With a strong focus on non-invasive therapy solutions, the company integrates research, development, production, and global distribution to deliver reliable medical technologies for modern healthcare needs.

StavroCare is committed to innovation in rehabilitation and preventive healthcare. Its product portfolio includes physiotherapy devices, microcirculation improvement systems, magnetic therapy equipment, and intelligent health assessment platforms. Designed for hospitals, rehabilitation centers, and home care environments, these solutions aim to enhance treatment efficiency, improve patient outcomes, and support long-term wellness management.

Backed by an experienced engineering team and strict quality control standards, StavroCare ensures that every product meets international performance and safety requirements. The company continuously invests in advanced manufacturing technologies and digital healthcare integration, enabling smarter and more connected medical solutions.
With a customer-oriented approach, Hangzhou StavroCare Medical Co., Ltd. provides OEM and ODM services tailored to global partners, helping brands bring competitive and innovative healthcare products to market. Dedicated to quality, reliability, and continuous improvement, StavroCare is building its reputation as a trusted supplier in the global non-invasive medical device industry.